Is Dry Eyes Normal with Fibroids?

Is Dry Eyes Normal with Fibroids?

Yes, dry eyes are a recognized but rarely discussed symptom associated with uterine fibroids. The shared mechanism is estrogen dominance and its downstream effect on lacrimal gland function — the same hormonal imbalance that drives fibroid growth also reduces tear film stability. The exception is mild fibroid cases with stable hormone levels, where ocular symptoms are less common.

---

Why Fibroids and Dry Eyes Share a Root Cause

Uterine fibroids are benign smooth-muscle tumors that are estrogen-dependent — they grow faster when estrogen is elevated relative to progesterone, a state commonly called estrogen dominance (Ciebiera et al., Journal of Clinical Medicine 2017; PMID: 28869579). What is less well known is that the lacrimal glands — the small glands behind your upper eyelids responsible for producing the aqueous layer of your tear film — contain both estrogen and androgen receptors.

When estrogen fluctuates or remains chronically elevated, these receptors are disrupted, reducing the gland's secretory capacity. At the same time, androgens (which are generally tear-protective) tend to be relatively suppressed in estrogen-dominant states, compounding the effect (Sullivan et al., Experimental Eye Research 2002; PMID: 12208243). The result is a thinner, less stable tear film that evaporates faster — the clinical picture of dry eye disease (DED).

This is not a coincidence or a stretch. A large epidemiological analysis found that hormonal contraceptive use — which creates a low-androgen, controlled-estrogen environment — was significantly associated with higher rates of clinically diagnosed dry eye (Truong et al., Investigative Ophthalmology & Visual Science 2014; PMID: 25082231). The same hormonal mechanics apply when natural estrogen levels are chronically dysregulated, as they often are with fibroids.

If you are also navigating other hormonally driven conditions alongside fibroids, it is worth knowing that ocular dryness appears across the spectrum: you can read more about why dry eyes appear with other hormone-sensitive conditions like endometriosis or explore the adenomyosis–dry eye connection for comparison.

---

The Estrogen–Lacrimal Gland Connection Explained

The lacrimal gland is not just a passive water source. It is an active secretory organ regulated by sex hormones, autonomic nerves, and local immune cells. Estrogen receptors alpha and beta are both expressed in lacrimal tissue, and their stimulation by fluctuating estrogen has a paradoxical effect: acute estrogen can briefly stimulate secretion, but chronic or unbalanced estrogen exposure tends to promote inflammation and fibrosis within the gland, ultimately impairing its output (Meehan & Sullivan, Progress in Retinal and Eye Research 2017; PMID: 28465162).

Another pathway involves prostaglandins. Fibroids are associated with elevated prostaglandin production, which contributes to heavy menstrual bleeding and pelvic inflammation. Prostaglandins — specifically PGE2 — also modulate meibomian gland secretion, the oil-producing glands that prevent tear evaporation. Disruption of these glands leads to evaporative dry eye, the most common form of DED.

In practical terms, this means a person with fibroids may experience:

• A gritty or sandy sensation in the eyes, especially in the morning or after screen use
• Paradoxical watery eyes (reflex tearing from a dry ocular surface)
• Blurred vision that clears with blinking
• Increased sensitivity to wind, air conditioning, or smoke
• Worsening symptoms in the week before menstruation, when progesterone drops sharply

That last point is clinically important. Just as dry eyes tend to worsen in the premenstrual window with PMS, fibroid patients frequently report that their ocular symptoms spike alongside other perimenstrual complaints.

---

How Fibroid-Related Inflammation Makes Dry Eyes Worse

Beyond hormones, fibroids drive a low-grade systemic inflammatory state. Elevated levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and vascular endothelial growth factor (VEGF) have all been documented in women with symptomatic fibroids (Chegini et al., Journal of Clinical Endocrinology & Metabolism 2003; PMID: 12531862). These same cytokines are implicated in the pathogenesis of dry eye disease — they destabilize the corneal epithelium, reduce goblet cell density, and promote a self-perpetuating inflammatory cycle on the ocular surface.

Iron deficiency is a second amplifier. Heavy menstrual bleeding from fibroids is one of the leading causes of iron-deficiency anemia in reproductive-age women. Iron is required for healthy red blood cell production, and inadequate oxygen delivery to the highly vascularized lacrimal gland impairs its secretory function. Nutritional depletion — including low omega-3 fatty acid status, which directly correlates with meibomian gland health — rounds out the picture.

The fibroid symptom cluster is broader than most people realize. Many women with fibroids also report unusual levels of exhaustion and unexplained weight gain around the midsection, all of which point back to the same hormonal and inflammatory underpinnings.

---

What Evidence Says About Omega-3s and Dry Eye

Of all the nutritional interventions studied for dry eye disease, omega-3 fatty acids have the most robust evidence base. EPA and DHA — the active marine omega-3s — work through multiple mechanisms relevant to fibroid patients:

1. Anti-inflammatory signaling: EPA is the precursor to the E-series resolvins, which actively resolve ocular surface inflammation rather than merely suppressing it.
2. Meibomian gland support: Omega-3s improve the lipid composition of meibomian secretions, reducing tear evaporation.
3. Lacrimal gland protection: DHA is highly concentrated in neural tissue, including the autonomic nerves that regulate lacrimal secretion.

A randomized controlled trial published in Cornea (Bhargava et al. 2013; PMID: 23552293) found that 1.5 g/day of EPA+DHA for six months significantly improved tear film break-up time and reduced Ocular Surface Disease Index (OSDI) scores compared with placebo in patients with dry eye. A larger 2018 DREAM trial (Asbell et al., NEJM 2018; PMID: 29652057) showed more nuanced results — omega-3 supplementation did not outperform refined olive oil placebo, likely because the placebo itself had modest omega-3 activity — but a subsequent re-analysis confirmed benefit in participants with the lowest baseline EPA+DHA status.

The takeaway: if your omega-3 intake is already adequate (oily fish 3+ times per week), supplementation may offer marginal additional benefit. If your diet is typical of the average American — dominated by omega-6-rich seed oils — there is meaningful room for improvement.

---

Vitamin D, Estrogen, and the Fibroid–Dry Eye Triangle

Vitamin D deficiency is significantly more prevalent in women with uterine fibroids compared with fibroid-free controls — multiple studies suggest the odds ratio for fibroid presence is roughly 2-fold higher in vitamin D-deficient women (Baird et al., Epidemiology 2013; PMID: 23514832). Vitamin D is not just a bone nutrient; it is an immunomodulatory steroid hormone that regulates inflammatory cytokine production in multiple tissue types, including lacrimal tissue.

Low vitamin D status therefore contributes to fibroids through reduced anti-proliferative signaling AND contributes to dry eye through inadequate lacrimal immune regulation — making it a genuine shared risk factor rather than a coincidence. Correcting vitamin D deficiency is one of the few interventions that plausibly addresses both conditions simultaneously.

Vitamin D3 (cholecalciferol) is more bioavailable than D2 (ergocalciferol) and is best paired with vitamin K2 in the MK-7 form, which directs calcium to bone and away from soft tissue (Vermeer et al., Thrombosis and Haemostasis 2012; PMID: 22461123). This D3+K2 pairing is especially relevant if supplementing at higher doses (2,000 IU+).

---

What This Means for Your Formula

If you have fibroids and are experiencing dry eye symptoms, the nutritional gap to address is usually one of three things: omega-3 insufficiency, vitamin D deficiency, or systemic inflammation — and often all three together. A personalized supplement approach should account for what your bloodwork actually shows rather than applying a blanket protocol.

Ones analyzes your lab results, wearable data, and health history to identify these specific gaps. Three ingredients from the Ones catalog are particularly relevant here:

Omega-3 (EPA+DHA): Ones includes pharmaceutical-grade omega-3 dosed at clinically relevant levels of combined EPA+DHA — calibrated to your dietary intake data and inflammatory markers, not a one-size-fits-all 1,000 mg capsule. The target is the 1,500–2,000 mg EPA+DHA range supported by ocular surface research.

Vitamin D3 + K2 (MK-7): Ones pairs D3 with K2 in the MK-7 form, matching the co-supplementation approach validated in clinical literature. Dose is individualized based on your serum 25-OH-D level — someone at 18 ng/mL needs a fundamentally different dose than someone at 38 ng/mL.

Zinc: Ones includes elemental zinc as a cofactor for vitamin A transport and as an anti-inflammatory agent that complements omega-3s at the ocular surface. Dosing is calibrated to avoid the copper-depletion risk that comes with unsupervised zinc supplementation above 25 mg/day.

Ones also includes a Histamine Support system blend, which is worth noting: histamine intolerance is a lesser-known but real co-occurring issue with fibroids, and histamine release can worsen ocular surface inflammation through mast cell activation on the conjunctiva.

Because Ones builds your formula from a curated catalog of ~70 clinically validated ingredients and structures it in either a 6 or 9-capsule daily plan selected by the AI based on your findings, there is no guesswork about what to combine or in what order.

---

When to See a Doctor

Supplement support addresses nutritional drivers of dry eye but does not replace evaluation for underlying causes. You should consult an ophthalmologist or optometrist if:

• Symptoms are severe enough to interfere with reading, driving, or daily tasks
• You have eye redness, pain, or changes in vision
• Dry eye has persisted for more than three months despite dietary changes
• You are considering hormonal interventions for fibroids (GnRH agonists can worsen dry eye by suppressing estrogen further)

For the fibroids themselves, gynecological evaluation determines whether watchful waiting, medication, or procedural intervention is appropriate. Nutritional optimization is a complement to that care, not a substitute.

---

Key Takeaways

• Dry eyes are a legitimate, hormonally driven symptom associated with uterine fibroids — they share an estrogen-dominance and lacrimal gland inflammation mechanism.
• The lacrimal gland contains estrogen and androgen receptors; chronic hormonal dysregulation impairs its secretory capacity and reduces tear film stability.
• Fibroid-related systemic inflammation (elevated IL-6, TNF-α) and iron-deficiency anemia from heavy bleeding further compromise ocular surface health.
• Omega-3 fatty acids (EPA+DHA at 1,500–2,000 mg/day), vitamin D3 paired with K2, and zinc are the best-evidenced nutritional supports for this specific overlap.
• Vitamin D deficiency is significantly more common in women with fibroids and independently raises dry eye risk — correcting it addresses both simultaneously.
• A personalized formula based on actual lab values — not guesswork — is the most efficient path to closing these nutritional gaps; platforms like Ones build these formulas from verified bloodwork and wearable data.